BUZZ-中期癌症疗法试验数据喜人,Arcellx 公司业绩大涨

路透中文
Dec 08
BUZZ-中期癌症疗法试验数据喜人,Arcellx 公司业绩大涨

12月8日 - ** 癌症疗法开发商ArcellxACLX.O股价盘前大涨9.8%至76.39美元

** 公司宣布 (link) Anito-cel 的中期试验结果呈阳性,Anito-cel 是一种治疗多发性骨髓瘤(一种血癌)的实验性癌症疗法。

** 该疗法针对复发和/或治疗无效的血癌

** 在试验的 117 名患者中,112 人的病情对疗法有反应,联合公司称

** 截至上一交易日收盘,ACLX年累计上涨1.6

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10